Dr. Balevic, <i>et al</i> reply
Stephen J. Balevic(Duke University), Michael Cohen‐Wolkowiez(Duke University), Brenna L. Hughes(Brown University), Amanda M. Eudy(Duke University), Daniel González(University of North Carolina at Chapel Hill), Christoph P. Hornik(Duke University), Megan E. B. Clowse(Duke University), Geeta K. Swamy(Unknown), Thomas P. Green(Duke University), Anil R. Maharaj(Clinical Research Institute), Laura E. Schanberg(Duke University)
Cited by 1
Related Papers
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials
|Arthritis & Rheumatology|2016|237
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children
|The Annals of Thoracic Surgery|2000|224
Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
|Journal of Women s Health|2009|221